| Identification | Back Directory | [Name]
3H-Imidazo[4,5-c]quinolin-4-amine, 2-butyl-8-(1-piperazinyl)- | [CAS]
2388520-33-8 | [Synonyms]
TLR7/8 agonist 4
3H-Imidazo[4,5-c]quinolin-4-amine, 2-butyl-8-(1-piperazinyl)- | [Molecular Formula]
C18H24N6 | [MOL File]
2388520-33-8.mol | [Molecular Weight]
324.42 |
| Chemical Properties | Back Directory | [Boiling point ]
643.2±50.0 °C(Predicted) | [density ]
1.253±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [form ]
Solid | [pka]
14.18±0.40(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
TLR7/8 agonist 4 (compound 41) is a potent TLR7/8 agonist. TLR7/8 agonist 4 has anti-cancer activity[1]. | [IC 50]
TLR7; TLR8 | [References]
[1] Shelley Erin ACKERMAN, et al. Macromolecule-supported tlr agonists. WO2020190762A1. |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|